酸性微环境激活μ阿片受体激动剂抑制结肠炎疼痛且无副作用
该临床前研究在DSS结肠炎小鼠模型中比较NFEPP与芬太尼的镇痛作用及副作用。NFEPP仅在酸化炎症组织激活MOPr,抑制结肠炎小鼠的内脏运动反应,而不影响对照小鼠;芬太尼则两组均抑制。NFEPP不引起便秘、呼吸抑制或多动,而芬太尼引起这些副作用。
要点
- NFEPP在结肠炎小鼠中抑制结直肠扩张的内脏运动反应,对照小鼠无此效应。
- 芬太尼在结肠炎和对照小鼠中均抑制内脏运动反应。
- NFEPP不引起便秘、呼吸抑制或多动,而芬太尼引起这些副作用。
核心结论
- 在临床前IBD模型中,NFEPP优先在炎症组织酸化微环境激活MOPr,产生镇痛作用而不引起呼吸抑制、便秘和多动。
研究设计与样本
- 研究在对照组小鼠和DSS结肠炎小鼠中比较NFEPP与芬太尼的镇痛作用,通过结直肠扩张的内脏运动反应评估。
- 采用膜片钳和细胞外记录评估伤害感受器激活;评估排便、呼吸和运动;离体组织时空标测评估结肠迁移运动复合波。
- 在HEK293细胞中研究NFEPP诱导的MOPr信号传导和转运。
主要发现
- NFEPP抑制结肠炎小鼠对结直肠扩张的内脏运动反应,但不抑制对照小鼠,与炎症结肠酸化一致。
- 芬太尼抑制两组小鼠的内脏运动反应。
- NFEPP抑制背根神经节神经元兴奋性,并在酸化而非生理条件下抑制结肠传入纤维的机械敏感性。
- 芬太尼减少结肠炎小鼠排便并引起呼吸抑制和多动,NFEPP无这些效应。
- NFEPP在生理pH下不影响结肠迁移运动复合波;在酸化细胞外条件下优先激活MOPr,抑制cAMP形成、招募β-arrestin并引发MOPr内吞。
临床怎么用
- NFEPP代表一种在炎症组织酸性微环境中优先激活MOPr的镇痛策略,可能用于IBD疼痛治疗而避免阿片类典型副作用。
局限性
- 本研究为临床前动物模型和细胞实验,结果尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The effectiveness of µ-opioid receptor (MOPr) agonists for treatment of visceral pain is compromised by constipation, respiratory depression, sedation and addiction. We investigated whether a fentanyl analogue, (±)-N-(3-fluoro-1-phenethylpiperidine-4-yl)-N-phenyl propionamide (NFEPP), which preferentially activates MOPr in acidified diseased tissues, would inhibit pain in a preclinical model of inflammatory bowel disease (IBD) without side effects in healthy tissues. DESIGN: Antinociceptive actions of NFEPP and fentanyl were compared in control mice and mice with dextran sodium sulfate colitis by measuring visceromotor responses to colorectal distension. Patch clamp and extracellular recordings were used to assess nociceptor activation. Defecation, respiration and locomotion were assessed. Colonic migrating motor complexes were assessed by spatiotemporal mapping of isolated tissue. NFEPP-induced MOPr signalling and trafficking were studied in human embryonic kidney 293 cells. RESULTS: NFEPP inhibited visceromotor responses to colorectal distension in mice with colitis but not in control mice, consistent with acidification of the inflamed colon. Fentanyl inhibited responses in both groups. NFEPP inhibited the excitability of dorsal root ganglion neurons and suppressed mechanical sensitivity of colonic afferent fibres in acidified but not physiological conditions. Whereas fentanyl decreased defecation and caused respiratory depression and hyperactivity in mice with colitis, NFEPP was devoid of these effects. NFEPP did not affect colonic migrating motor complexes at physiological pH. NFEPP preferentially activated MOPr in acidified extracellular conditions to inhibit cAMP formation, recruit β-arrestins and evoke MOPr endocytosis. CONCLUSION: In a preclinical IBD model, NFEPP preferentially activates MOPr in acidified microenvironments of inflamed tissues to induce antinociception without causing respiratory depression, constipation and hyperactivity.
引用
- Jiménez-Vargas NN, Yu Y, Jensen DD, et al. Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects. Gut. 2021. PMID: 33785555. doi:10.1136/gutjnl-2021-324070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。